홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Triphenylphosphine → 4-(piperidin-4-yloxy)-1H-indazole

HRID 1269780
노트
인쇄 미리보기

반응식

HRID 1269780 반응식
[NH:1]1[C:9]2[CH:8]=[CH:7][CH:6]=[C:5]([OH:10])[C:4]=2[CH:3]=[N:2]1.O[CH:12]1[CH2:17][CH2:16][N:15](C(OC(C)(C)C)=O)[CH2:14][CH2:13]1.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.N(C(OCC1C=CC=CC=1)=O)=NC(OCC1C=CC=CC=1)=O.ClCCl.Cl.O1CCOCC1>O1CCCC1.CO>[NH:15]1[CH2:16][CH2:17][CH:12]([O:10][C:5]2[CH:6]=[CH:7][CH:8]=[C:9]3[C:4]=2[CH:3]=[N:2][NH:1]3)[CH2:13][CH2:14]1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

8

반응물 5

HCID 11776TriphenylphosphineHCID 643502Tert-butyl 4-hydroxypiperidine-1-carboxylateHCID 204431481,4-Dioxane hydrochlorideHCID 86593608Dibenzyl azodicarboxylate dichloromethaneHCID 1357424501H-indazol-4-ol

생성물 1

HCID 229336964-(piperidin-4-yloxy)-1H-indazole수율 32%

시약·촉매·용매 2

HCID 887Methanol용매HCID 8028Tetrahydrofuran용매

실험 절차

To a solution of 1H-indazol-4-ol (200 mg, 1.49 mmol) in tetrahydrofuran (10 ml) were added tert-butyl 4-hydroxypiperidine-1-carboxylate (300 mg, 1.49 mmol), triphenylphosphine (430 mg, 1.64 mmol) and a 40%-dibenzyl azodicarboxylate-dichloromethane solution (0.855 ml, 1.79 mmol) at 0° C. After 1 hour, the mixture thus obtained was warmed up to room temperature. After stirring overnight, the reaction solution was concentrated under reduced pressure, and the resulting residue was dissolved in chloroform (30 ml) and washed with a 1M-aqueous sodium hydroxide solution (20 ml). Extraction with chloroform (30 ml) was carried out again and the organic layer was dried over anhydrous magnesium sulfate. The organic layer dried was concentrated under reduced pressure and the resulting residue was purified by a silica gel column chromatography (eluent: hexane/ethyl acetate). The mixture thus obtained was dissolved in methanol (2 ml) and 4N-hydrochloric acid-dioxane (2 ml) was added thereto at room temperature. After 2 hours, the reaction solution was concentrated under reduced pressure, and the resulting residue was dissolved in methanol (5 ml) and the pH was adjusted to 10 by dropwise addition of a 2M aqueous sodium hydroxide solution. The resulting mixed solution was concentrated under reduced pressure, dried and then purified by a silica gel column chromatography (eluent: chloroform/methanol=10/1→chloroform/methanol/(1%-NH3 aq)=10/1) to obtain 4-(piperidin-4-yloxy)-1H-indazole (103 mg, 32%).

후처리

  1. customat 0° C
  2. customthe mixture thus obtained
  3. concentrationthe reaction solution was concentrated under reduced pressure
  4. dissolutionthe resulting residue was dissolved in chloroform (30 ml)
  5. washwashed with a 1M-aqueous sodium hydroxide solution (20 ml)
  6. extractionExtraction with chloroform (30 ml)
  7. dry with materialthe organic layer was dried over anhydrous magnesium sulfate
  8. customThe organic layer dried
  9. concentrationwas concentrated under reduced pressure
  10. customthe resulting residue was purified by a silica gel column chromatography (eluent: hexane/ethyl acetate)
  11. customThe mixture thus obtained
  12. customat room temperature
  13. waitAfter 2 hours
  14. concentrationthe reaction solution was concentrated under reduced pressure
  15. dissolutionthe resulting residue was dissolved in methanol (5 ml)
  16. additionthe pH was adjusted to 10 by dropwise addition of a 2M aqueous sodium hydroxide solution
  17. additionThe resulting mixed solution
  18. concentrationwas concentrated under reduced pressure
  19. customdried
  20. custompurified by a silica gel column chromatography (eluent: chloroform/methanol=10/1→chloroform/methanol/(1%-NH3 aq)=10/1)

출처 및 근거

ORD 기록
ord-77bdb2e5ad104e07aaadbea7f47216fa
출처 데이터셋
uspto-grants-2007_04
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07199147B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트